What is Screening ?

 

How is screening different from diagnostic testing?





The Unibiosicence Rapid Antigen tests are suitable for diagnostic testing and screening testing.

Admin

Diagnostic testing: Diagnostic testing identifies current infection at the individual level and is performed when a person has signs or symptoms of infection, or when a person is asymptomatic but has recent known or suspected exposure.

Screening testing: Screening testing looks for individual infections in a group even if there is no reason to suspect those individuals are infected. Screening involves testing asymptomatic individuals who do not have known or suspected exposure to COVID-19 in order to make individual decisions based on the test results.

The Unibiosicence Rapid Antigen tests are suitable for screening testing.

Unibioscience Covid-19 Rapid Nasal Antigen Test

nasal_antigen_test
Single Pack

Unibioscience Covid-19 Rapid Nasal Antigen Test

antigen_nasal_test-1
14 pieces in a box

Unibioscience Covid-19 Rapid Saliva Antigen Test

salivatest_boxs
12 test in a box

Unibioscience Covid-19 Rapid Nasopharynx Antigen Test

antigentest_new (2)
Bulk Pack 25 test in a box
 

How does one set up a screening program?



Schools, workplaces, communities, and others looking to establish testing programs to screen asymptomatic individuals without known or suspected exposure are using various options, including;
  1. Using a test authorized for screening like Unibioscience Rapid Antigen Test.
  2. Health care providers on behalf of the program ordering an Unibioscience Rapid Antigen diagnostic test for screening.

Regardless of the test selected, it’s important to monitor for updates from the test developer for new information regarding the performance of the selected test with emerging mutations of the virus in your community.
It is important to note that testing, even serial testing, is of limited value if it is not combined with appropriate mitigations for individuals who test positive (such as quarantine), good contact tracing, and effective behavioural protocols (such as mask-wearing, hand washing and social distancing), even for individuals who test negative.


Source: CDC, FDA